276 related articles for article (PubMed ID: 18423623)
1. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
Bird RC; Deinnocentes P; Lenz S; Thacker EE; Curiel DT; Smith BF
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):289-304. PubMed ID: 18423623
[TBL] [Abstract][Full Text] [Related]
2. An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.
Bird RC; Deinnocentes P; Church Bird AE; van Ginkel FW; Lindquist J; Smith BF
Cancer Immunol Immunother; 2011 Jan; 60(1):87-97. PubMed ID: 21069323
[TBL] [Abstract][Full Text] [Related]
3. Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines.
Whitley EM; Bird AC; Zucker KE; Wolfe LG
Anticancer Res; 1995; 15(3):923-9. PubMed ID: 7645983
[TBL] [Abstract][Full Text] [Related]
4. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.
Milner RJ; Salute M; Crawford C; Abbot JR; Farese J
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):273-84. PubMed ID: 17027091
[TBL] [Abstract][Full Text] [Related]
5. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
Koide T; Iinuma H; Fukushima R
Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
[TBL] [Abstract][Full Text] [Related]
6. In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcoma.
Rodeberg DA; Erskine C; Celis E
J Pediatr Surg; 2007 Aug; 42(8):1396-402. PubMed ID: 17706503
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
Avigan D
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6347S-52S. PubMed ID: 15448029
[TBL] [Abstract][Full Text] [Related]
8. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
Kim JH; Majumder N; Lin H; Chen J; Falo LD; You Z
Mol Ther; 2005 Jun; 11(6):941-9. PubMed ID: 15922965
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
Zhang Y; Ma B; Zhou Y; Zhang M; Qiu X; Sui Y; Zhang X; Ma B; Fan Q
Breast Cancer Res Treat; 2007 Nov; 105(3):277-86. PubMed ID: 17187233
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
Sas S; Chan T; Sami A; El-Gayed A; Xiang J
Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
[TBL] [Abstract][Full Text] [Related]
13. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
[TBL] [Abstract][Full Text] [Related]
14. Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells.
Tamura K; Yamada M; Isotani M; Arai H; Yagihara H; Ono K; Washizu T; Bonkobara M
Vet J; 2008 Jan; 175(1):126-9. PubMed ID: 17208475
[TBL] [Abstract][Full Text] [Related]
15. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J; Koido S; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
17. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
20. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
